China CAR-T Cell Therapy Market: Advanced Autologous Platforms and Closed-System Manufacturing Solutions Accelerating Research
Surging domestic incidence of relapsed and refractory hematological malignancies such as multiple myeloma and diffuse large B-cell lymphoma (DLBCL), expanding National Medical Products Administration (NMPA) approvals for innovative cellular products, and continuous biotechnology innovations in chimeric antigen receptor T-cell (CAR-T) genetic engineering and lentiviral vector transduction are...
0 Commentarii 0 Distribuiri 3 Views 0 previzualizare
social art-inpa https://social.art-inpa.com